Literature DB >> 4215443

Intracellular killing of different strains of Pseudomonas aeruginosa by human leucocytes.

E A Roe, R J Jones.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4215443      PMCID: PMC2072652     

Source DB:  PubMed          Journal:  Br J Exp Pathol        ISSN: 0007-1021


× No keyword cloud information.
  10 in total

1.  Immunity to Pseudomonas pyocyanea in man.

Authors:  J E FOX; E J LOWBURY
Journal:  J Pathol Bacteriol       Date:  1953-04

Review 2.  Infectious complications of neoplastic disease.

Authors:  D Armstrong; L S Young; R D Meyer; A H Blevins
Journal:  Med Clin North Am       Date:  1971-05       Impact factor: 5.456

3.  Death after transplantation; an analysis of sixty cases.

Authors:  R B Hill; B E Dahrling; T E Starzl; D Rifkind
Journal:  Am J Med       Date:  1967-03       Impact factor: 4.965

4.  The invasion of burned skin by Pseudomonas aeruginosa.

Authors:  S A Carney; R E Dyster; R J Jones
Journal:  Br J Dermatol       Date:  1973-06       Impact factor: 9.302

5.  The role of polymorphonuclear leucocytes in protecting mice vaccinated against Pseudomon as aeruginosa infections.

Authors:  R J Jones; R E Dyster
Journal:  Br J Exp Pathol       Date:  1973-08

6.  Evaluation of neutrophil granulocyte functions.

Authors:  C O Solberg
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1972

7.  Human immunity to Pseudomonas aeruginosa. I. In-vitro interaction of bacteria, polymorphonuclear leukocytes, and serum factors.

Authors:  L S Young; D Armstrong
Journal:  J Infect Dis       Date:  1972-09       Impact factor: 5.226

8.  Passive immunisation against Gram-negative bacilli in burns.

Authors:  R J Jones
Journal:  Br J Exp Pathol       Date:  1970-02

9.  Serogroups of Pseudomonas aeruginosa and the immune response of patients with cystic fibrosis.

Authors:  E Diaz; L L Mosovich; E Neter
Journal:  J Infect Dis       Date:  1970-03       Impact factor: 5.226

10.  Pseudomonas aeruginosa: immune status in patients with cystic fibrosis.

Authors:  R G Doggett; G M Harrison
Journal:  Infect Immun       Date:  1972-10       Impact factor: 3.441

  10 in total
  6 in total

Review 1.  Cystic fibrosis, pathophysiological and clinical aspects.

Authors:  H J Neijens; M Sinaasappel; R de Groot; J C de Jongste; S E Overbeek
Journal:  Eur J Pediatr       Date:  1990-08       Impact factor: 3.183

2.  Unusual mechanism of pathogenicity of Pseudomonas aeruginosa isolates from patients with cystic fibrosis.

Authors:  B Tümmler
Journal:  Infection       Date:  1987 Jul-Aug       Impact factor: 3.553

3.  Role of nonagglutinating antibody in the protracted immunity of vaccinated mice to Pseudomonas aeruginosa infection.

Authors:  M R Moody; R W Kessel; V M Young; P Fiset
Journal:  Infect Immun       Date:  1978-09       Impact factor: 3.441

4.  Susceptibility of lipopolysaccharide mutants to the bactericidal action of human neutrophil lysosomal fractions.

Authors:  R F Rest; M H Cooney; J K Spitznagel
Journal:  Infect Immun       Date:  1977-04       Impact factor: 3.441

5.  Protection against Gram-negative infection by 'super-active' antigen.

Authors:  E A Roe
Journal:  Immunology       Date:  1976-11       Impact factor: 7.397

6.  The role of extracellular products of Pseudomonas aeruginosa in the pathogenesis of infection; an experimental study employing intraperitoneal diffusion chambers.

Authors:  R M Al-Ssum; D M Harris; J C Underwood
Journal:  Br J Exp Pathol       Date:  1980-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.